Lockheed Martin or Raytheon: Which Defense Stock Has More Upside Potential?
UK has no plans to buy rapid COVID-19 test favoured by US and WHO
We Don't Need A Higher Minimum Wage; We Need To Fix Our Money
AAR Soars 10%, Beats 1Q Estimates Despite Covid’s Impact
From Pistol-Dollar To Petro-Dollar To Pharma-Dollar...
Lessons On Inflation From The Past
The Gathering Super Tantrum
Failure To Launch New Fiscal Stimulus Would Have Catastrophic Consequences For The US Economy
Week Ahead – Let the debates begin!
Asia follows Wall Street south
Exclusive: Top adviser steps aside from FDA Covid-19 vaccine reviews over potential conflict
Gilead To Pay $97M To Settle Kickback Debacle Over Letairis Drug
RedHill Gets Brazil’s Nod For Covid-19 Study With Opaganib
Was Monday's Big Selloff A Plea For More Stimulus?
Global Stocks Plunge On Bank, Election, Virus Fears; Treasuries, Dollar Spike
From Unity to Disrupt, tech has an especially optimistic week
China Is Killing The Dollar
Peter Schiff: When Exactly Are They Going To Deal With The Debt?
The Fed Is Planning Another Ultralong Period of Ultralow Rates
Futures Flat Ahead Of Quad Witching Volume Surge
Futures Slide After Fed "Not-Dovish-Enough", Tech Tumbles On Reflation Rotation Fears
Supercell’s CEO talks about its majority owner Tencent, finding its next hit, and more
Broad U.S. rollout of coronavirus vaccine could happen mid-2021: CDC
500 US Companies Have Filed For Bankruptcy
Novavax Inks Deal With India For 2B Covid-19 Vaccine Doses In 2021
Regeneron tests COVID-19 antibody therapy in UK’s RECOVERY trial
Trial backs Lilly’s Olumiant plus remdesivir as combo COVID-19 therapy
Bill Gates Slams FDA, Doubts Agency Can Be Trusted With COVID-19 Vaccine
US Close – All about M&A today, Stopgap likely, OPEC+ to stay the course, Gold shines, Biden Momentum
Johnson & Johnson Kicks Off Phase 2 Covid-19 Vaccine Trial In Spain - Report